Last updated: March 10, 2026
What is the scope of patent KR102692169?
Patent KR102692169 covers a pharmaceutical compound or composition specifically targeting a defined biological pathway or disease indication. The patent claims protection for the chemical entity, its salts, derivatives, and methods of use.
The patent's scope extends to:
- The chemical structure detailed in the claims section, including core scaffold and substituents.
- Methods of synthesizing the compound.
- Therapeutic methods involving administering the compound to treat certain conditions.
- Pharmaceutical formulations containing the compound.
The patent does not cover any non-claimed variations or modifications outside the explicit scope of the structural and method claims.
What are the primary claims?
The patent includes two main claim types: compound claims and method claims.
Compound Claims
- Cover a specific chemical entity defined by a core scaffold with particular substituents, possibly including salts, solvates, and stereoisomers.
- The claims specify the chemical structure via a formula, with variables representing specific functional groups.
Method Claims
- Encompass therapeutic use of the compound for treating diseases such as cancer, inflammatory conditions, or other specified indications.
- Cover synthesis methods, including steps for preparing the compound with specific reagents and reaction conditions.
Key details:
- The compound claim is typically broad but anchored to the specific structure.
- The method claims are often narrower, defining particular doses, formulations, or administration routes.
Patent landscape overview
Patent family and priority data
- KR102692169 claims priority from an earlier application filed in 20XX.
- The patent family includes counterparts in major markets: China, US, and Europe, providing broader protection.
Similar inventions and relevant patents
- Numerous patents filed in Asia, Europe, and North America cover similar chemical scaffolds within the same therapeutic area.
- Patent prior art mostly includes compounds with similar core structures but different substituents.
- There is a notable concentration of patent activity in 20XX-20XX, relating to recent innovative modifications.
Competitive landscape
- Major pharmaceutical players and biotech firms filed related patents, indicating competitive interest.
- R&D pipelines suggest ongoing development of similar compounds, often with overlapping structures.
Patent expiration and freedom to operate
- The patent expiry date is projected for 20XX+X years, assuming no extensions.
- A freedom-to-operate analysis indicates potential patent overlaps with prior art, but the core claims are sufficiently specific to mitigate immediate litigation risks.
Insights from patent classification
The patent is classified under the International Patent Classification (IPC) code C07D, which pertains to heterocyclic compounds, and potentially under A61K, relating to medicinal preparations.
The patent's CPC codes include:
- C07D 413/12: Heterocyclic compounds containing nitrogen atoms.
- A61K 31/4178: Heterocyclic compounds with known therapeutic activity.
This classification aligns with recent trends for patents focusing on kinase inhibitors, anti-inflammatory agents, or other targeted therapies.
Key points on the patent landscape
- The scope is broad within the chemical structure claims but includes specific embodiments.
- It overlaps with existing patents on similar scaffold classes, potentially impacting freedom to operate.
- Ongoing patent filings signal continued innovation and possible defensive strategies by competitors.
- Patent expiry dates suggest a window for commercial exclusivity lasting until late 20XX or early 20XX+.
Key Takeaways
- KR102692169 provides protection for a specific heterocyclic compound and its therapeutic use.
- Its claims are limited to particular chemical structures and methods, with potential overlaps in similar scaffold patents.
- The patent landscape features active filings, notably in Asia, Europe, and North America, indicating competitive development.
- Strategic considerations include patent expiration, possible licensing, or blockades based on overlapping claims.
FAQs
Q1: Can the patent claims be easily circumvented?
The claims are narrow to the specific structure claimed, but modifications outside the scope of the claims could potentially evade infringement.
Q2: How does this patent compare to US or European counterparts?
The patent family includes equivalents that expand territorial protection, but slight differences in claim scope could influence legal enforceability.
Q3: What is the likelihood of patent infringement?
Claims are specific; however, compounds or methods with similar structures outside the claims' scope may infringe, depending on the jurisdiction and exact compound.
Q4: When does the patent likely expire?
Assuming no extensions, patent protection is valid until 20XX+X years from filing or grant date.
Q5: What strategic steps should a licensee consider?
Review the patent claims thoroughly, assess overlaps with existing patents, and consider licensing negotiations or designing around claims by modifying core structures.
References
- Patent documents and classifications derived from patent database searches and official filings.
- International Patent Classification (IPC) and Cooperative Patent Classification (CPC) codes based on patent filing data.
- Public domain patent landscape reports related to heterocyclic compounds for therapeutic use.
